Global Tumor Ablation Market

Tumor Ablation Market Size, Share, Growth Analysis, By Technology (Radiofrequency Ablation, Microwave Ablation), By Treatment (Surgical Ablation, Laparoscopic Ablation), By Application (Kidney Cancer, Liver Cancer), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2494 | Region: Global | Published Date: September, 2024
Pages: 219 | Tables: 95 | Figures: 76

Tumor Ablation Market Insights

Global Tumor Ablation Market size was valued at USD 1.48 Billion in 2022 and is poised to grow from USD 1.68 Billion in 2023 to USD 4.63 Billion by 2031, by rising at a CAGR 13.5% during the forecast period (2024-2031).

The increasing prevalence of cancer & the strong desire for safer therapeutic choices are important factors driving market expansion. According to the WHO, by 2030, 10-11 million instances of cancer are expected to be diagnosed globally each year. The number of new cases of cancer in low-income nations is anticipated to rise by more than 80%, compared to half the pace in high-income countries (40%). Lucrative potential for expansion in currently existing therapeutic choices, as well as a strong desire for minimally & non-invasive therapies, are projected to drive the market in the future years.

The growing preference of surgeons and patients for minimally invasive procedures due to benefits such as faster recovery, patient comfort, the shorter turnaround time is likely to boost demand for advanced tumor ablation methods over the forecast period. When opposed to conventional therapy, advanced tumor ablation procedures are often conducted on an outpatient basis & lack any hospital admission, considerably lowering total healthcare costs. Ablative operations are the primary treatment for tiny tumors. As a result, its procedural number is indirectly affected by yearly cancer detection rates. The market was considerably impacted in 2020 as the number of cases of cancer that were newly diagnosed decreased significantly during COVID due to less screening measures done by relevant authorities.

According to a survey by Our World in Data (OWD), an initiative of Global Change Data Lab, more than 70% of cancer diagnoses occurred in persons over the age of 50. The number is likely to rise in lockstep with the growing senior population. As the body's basic systems deteriorate with age, the aging population is the primary target group for noninvasive ablation procedures. As a result, the rising aging population is predicted to drive up demand for tumor ablation procedures over the projection period.

The drivers motivating market participants to consistently upgrade and launch advanced products are technological advancements to improve accuracy, mobility, and cost-effectiveness. These technological developments include image-guided devices, HIFU, and cryoablation. One of the upcoming techniques that is expected to play a big role in market expansion is the use of the cooled radiofrequency degeneration technique with externally chilled radiofrequency probes to increase the size of the lesion. This procedure allows for total degeneration of the sacroiliac joint, resulting in pain relief.

US Tumor Ablation Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Tumor Ablation Market size was valued at USD 1.48 Billion in 2022 and is poised to grow from USD 1.68 Billion in 2023 to USD 4.63 Billion by 2031, by rising at a CAGR 13.5% during the forecast period (2024-2031).

Key companies are increasing their expenditure on R&D to produce minimally invasive and new tumor ablative therapies in order to gain a huge market share. For example, Boston Scientific Corporation got Health Canada certification in 2021 for its advanced freezing system, ICEfxTM. The device has a lower footprint, is portable, and offers a potent alternative to current cryoablation systems. 'Medtronic plc (Ireland) ', 'Boston Scientific Corporation (US) ', 'Johnson & Johnson (Ethicon, Inc.) (US) ', 'AngioDynamics, Inc. (US) ', 'EDAP TMS S.A. (France) ', 'SonaCare Medical, LLC (US) ', 'Merit Medical Systems, Inc. (US) ', 'Misonix, Inc. (US) ', 'HealthTronics, Inc. (US) ', 'Galil Medical Ltd. (US) ', 'IceCure Medical Ltd. (Israel) ', 'Monteris Medical, Inc. (Canada) ', 'Hologic, Inc. (US) ', 'Symple Surgical Inc. (US) ', 'BVM Medical Limited (UK) ', 'Ablatherm (Esaote S.p.A.) (Italy) ', 'Bioventus LLC (US) ', 'CEVOTEC (Germany) ', 'Fujifilm Holdings Corporation (Japan) ', 'InSightec Ltd. (Israel) ', 'Philips Healthcare (Netherlands)'

The rising prevalence of cancer globally, particularly in lung, liver, kidney, and breast cancers, is a major driver for the tumor ablation market. Tumor ablation techniques offer minimally invasive alternatives to surgery for the treatment of localized tumors, providing effective therapeutic options to patients who may not be suitable candidates for surgery.

Technological Advancements: The tumor ablation market is witnessing continuous technological advancements, leading to the development of more advanced and precise ablation techniques. These advancements include the integration of imaging modalities for real-time guidance, the use of robotic systems for improved accuracy, and the development of new energy sources for ablation. These technological advancements enhance the efficacy and safety of tumor ablation procedures.

In 2023, North America held a dominant revenue share of 34.42% in the market. The government's support of high-quality healthcare, the region's high purchasing power parity, the accessibility of reimbursements, and the rising incidence of cancer are major drivers of growth. For example, the Patient Protection and Affordable Care Act (PPACA) in the United States encourages access to high-quality, reasonably priced healthcare by lowering the cost of healthcare for both individuals and the government through health coverage programmed. Furthermore, the precision medicine movement involves developing customized approaches based on distinct features of illnesses. Therefore, it is projected that these government actions will enhance the healthcare system, driving market expansion. In 2023, Europe had a sizable portion. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Tumor Ablation Market

Report ID: SQMIG35A2494

$5,300
BUY NOW GET FREE SAMPLE